EUVIMEDEUVIMED entdecken
Crossref

Weekly HIV pill moves closer but vaccine studies face new questions

Jon Cohen

Science · 06.08.2026 · 393 (6811) · 549-550

DOI: 10.1126/science.ael2155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 06.08.2026. Verfasst von Jon Cohen. Beteiligte Einrichtung: Rio de Janeiro. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV Antibodies, HIV Infections, HIV-1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Potent antibodies that researchers hope vaccines can elicit didn’t prevent HIV in a major trial

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesHIV AntibodiesHIV InfectionsHIV-1Pre-Exposure ProphylaxisAcetamidesIndazolesAnti-HIV AgentsDeoxyadenosinesHumansDrug Combinations

Substanzen

AIDS VaccinesHIV AntibodieslenacapavirislatravirAcetamidesIndazolesAnti-HIV AgentsDeoxyadenosinesDrug Combinations

Autor:innen und Institutionen

  • Rio de Janeiro.

Zitieren

APA

Cohen, J. (2026). Weekly HIV pill moves closer but vaccine studies face new questions. Science, 393(6811), 549-550. https://doi.org/10.1126/science.ael2155

Vancouver

Cohen J. Weekly HIV pill moves closer but vaccine studies face new questions. Science. 2026;393(6811):549-550. doi:10.1126/science.ael2155

BibTeX
@article{Cohen2026,
  author = {Cohen, Jon},
  title = {Weekly HIV pill moves closer but vaccine studies face new questions},
  journal = {Science},
  year = {2026},
  volume = {393},
  number = {6811},
  pages = {549--550},
  doi = {10.1126/science.ael2155}
}
Kostenlos starten →